Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jul 1;108(7):1724-1725.
doi: 10.3324/haematol.2022.282273.

Terrific cells for SARS-CoV-2

Stephen Gottschalk  1
Affiliations
Editorial

Terrific cells for SARS-CoV-2

Stephen Gottschalk. Haematologica. .
No abstract available

PubMed Disclaimer

References

    1. Vasileiou S, Hill L, Kuvalekar M, et al. . Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients Haematologica. 2023;108(7):1840-1850. - PMC - PubMed
    1. Conway SR, Keller MD, Bollard CM. Cellular therapies for the treatment and prevention of SARS-CoV-2 infection. Blood. 2022;140(3):208-221. - PMC - PubMed
    1. Keller MD, Harris KM, Jensen-Wachspress MA, et al. . SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein. Blood. 2020;136(25):2905-2917. - PMC - PubMed
    1. Bertoletti A, Le Bert N, Tan AT. SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic. Immunity. 2022;55(10):1764-1778. - PMC - PubMed
    1. Tzannou I, Papadopoulou A, Naik S, et al. . Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2017;35(31):3547-3557. - PMC - PubMed

Publication types